Requests similar to 'Public knowledge of communication' (page 3)
Purchase of Pfizer Comirnaty JN.1 and Comirnaty Omicron XBB.1.5
Response by Ministry of Health to John Armstrong on .
Partially successful.
Kia ora John
Thank you for your request for official information, received 4 November
2025.
Please find attached response to your request...
Purchases of Covid-19 vaccines
Response by Ministry of Health to New Zealand Council for Civil Liberties on .
Successful.
Kia ora New Zealand Council for Civil Liberties
Thank you for your request for official information, which was transferred
to Pharmac by the Min...
Suspicious Medicine Usage
Response by Ministry of Health to David Robinson on .
Awaiting classification.
Kia ora David
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac
___...
Assessment bias toward new medicines - Ivermectin and Pfizer antiviral PF-07321332
Response by Ministry of Health to Adam Irish on .
Partially successful.
Kia ora Adam
Please find a response to your request attached with this email.
Ngā mihi
Melody Willis ([1]she/her) | Government Se...
Procurement process for Cormack Draper
Response by Pharmaceutical Management Agency to Harris Leigh on .
Partially successful.
Tçnâ koe Harris
Please find a response to your below request for information attached to
this email.
Ngâ mihi, nâ
Melody Willis...
Kia ora T Murray
Please find a response to your request attached to this email.
Ngâ mihi,
Katy Carlson (she/her) | Government Services Advisor
____...
Trikafta "27 more years at full health" claim.
Response by Pharmaceutical Management Agency to Laydan Mortensen on .
Successful.
Kia ora Laydan
Thank you for your request for official information, which Pharmac received on 17 January 2025. The reference number for your request i...
MoH criteria for Special Authority application of stimulant medication
Response by Pharmaceutical Management Agency to Cody C on .
Information not held.
Kia ora Cody
Please find a response to your request attached to this email.
Ngâ mihi,
Katy Carlson (she/her) | Government Services Advisor
________...
Rolling reviews of safety & efficacy of (non-mRNA gene therapy) COVID-19 treatments
Response by Pharmaceutical Management Agency to J Bruning on .
Successful.
Kia ora
Please find a response to your request for information attached with this email.
Ngā mihi
Melody Willis (she/her) | Government Services Adv...
The total legal costs incurred by Pharmac in relation to proceedings: CIV-2024-404-845 – Whittome v Director-General of Health
Response by Pharmaceutical Management Agency to John Armstrong on .
Awaiting classification.
Tçnâ koe John Armstrong
This email acknowledges receipt of your Official Information Act (1982)
(OIA)request of 13 July 2026 to Pharmac for the...
Tçnâ koe
Please find a response to your request for information attached.
Ngâ mihi, nâ
Melody Willis (she/her) | Government Services Advisor
______...
Stimulant medicine ADHD lisdexamfetamine - clear health benefit - efficacy and safety data
Response by Pharmaceutical Management Agency to J Bruning on .
Partially successful.
Kia ora J
Thank you for your request for official information, which Pharmac received on . The reference number for your request is: 2025-26-042
You...
7 - ADHD Medicines, Funding, Access, and Equity
Response by Pharmaceutical Management Agency to Elspeth Baker-Vevers on .
Partially successful.
Kia ora Elspeth
Thank you for your request for official information, which Pharmac received on 2 December 2025. The reference number for your request...
Covid19 XBB Vaccine availability
Response by Pharmaceutical Management Agency to Daniel Richards on .
Information not held.
Kia ora Daniel
Please find a response to your request attached to this email.
Ngâ mihi,
Katy Carlson ([1]she/her) | Government Se...
Kia ora Simon
Thank you for your request for information, received by Pharmac on 5 February 2024. Your request has been received and logged. Our refer...
Kia ora Chris
Please find a response to your request attached to this email.
Ngâ mihi,
Katy Carlson ([1]she/her) | Government Se...
Supporting/supplementary documentation to the 1 & 2 November 2018 PTAC minutes on funding of Whole Thyroid Extract and Liothyronine
Response by Pharmaceutical Management Agency to Belinda Hodson on .
Awaiting classification.
Good morning Belinda
Please find attached correspondence in relation to your recent OIA request (ref 2019-2-129).
Kind regards
Susan Robertson
Susa...
Approval of PHARMAC funded thyroid medications
Response by Pharmaceutical Management Agency to Belinda Hodson on .
Partially successful.
Good afternoon Belinda.
Please find attached our response to your request for PTAC minutes and the Endocrinology Subcommittee minutes that recommended...
Consumer Advisory Committee (CAC)
Response by Pharmaceutical Management Agency to john luke on .
Successful.
Good afternoon John
Please find attached PHARMAC's response to your recent request for information about CAC membership.
Kind regards, Susan
Susan...
Regulatory Status and Use of “Kostaive” (Zapomeran) Vaccine in New Zealand
Response by Ministry of Health to John Armstrong on .
Successful.
Kia ora John
Please find attached a letter regarding your request for official
information. If you wish to discuss any aspect of your re...
Communications regarding funding of Freestyle Libre monitors
Response by Pharmaceutical Management Agency to Harry Peterson on .
Awaiting classification.
Kia ora Harry,
Please see attached for your OIA request 😊
Arihia Gray [1](she/her) | Policy advisor
13 September 2022
Harry Peterson
<...
PrEP Correspondence
Response by Pharmaceutical Management Agency to Gemma Crawley on .
Information not held.
Hi Gemma
Sorry - by timeframe - I meant the time period for the correspondence you want us to include - ie how far back do you want us to search.
If th...
List of most most costly and most prescribed medications
Response by Pharmaceutical Management Agency to Sam Wagener on .
Refused.
Dear Sam
Thank you for your request below under the Official Information Act, 1982.
The information requested appears to be more closely associated to...
Under 40s - extent of co-prescribing for ADHD, anxiety, depression.
Response by Pharmaceutical Management Agency to J Bruning on .
Partially successful.
Kia ora Jodie,
Please find attached a response to your Official Information Act request,
which was received on 2 October 2024.
Please cont...
Dispensed drugs, media and events information request
Response by Pharmaceutical Management Agency to Joe Heihei on .
Awaiting classification.
Dear Joe
Please see attached the response to your OIA request.
Kind regards
Dean Zeng
PHARMAC
25 May 2018
Dear Joe
REQUEST FO...